atenolol has been researched along with Parkinson Disease in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Liu, G | 1 |
| Chen, J | 1 |
| Reddy, PS | 1 |
| Yoon, IS | 1 |
| Zhang, M | 1 |
| Zhang, B | 1 |
| Barber, JR | 1 |
| Ng, SC | 1 |
| Barajas García-Talavera, F | 1 |
| Rodríguez Díaz, M | 1 |
| Pérez de Paz, A | 1 |
2 other studies available for atenolol and Parkinson Disease
| Article | Year |
|---|---|
Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives: their cytoprotection effect from rotenone toxicity and preliminary DMPK properties.
Topics: Animals; Cytoprotection; Insecticides; Male; Microsomes, Liver; Parkinson Disease; Rats; Rotenone; S | 2009 |
[Atenolol in the control of parkinsonian tremor].
Topics: Atenolol; Humans; Male; Middle Aged; Parkinson Disease | 1985 |